ADAMTS5 Antibody [Allophycocyanin]
Novus Biologicals, part of Bio-Techne | Catalog # AF2198A

Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Immunoprecipitation, Western Blot
Label
Allophycocyanin (Excitation = 620-650 nm, Emission = 660-670 nm)
Antibody Source
Polyclonal Goat IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Mouse myeloma cell line NS0-derived recombinant human ADAMTS5
Ser262-Pro622
Accession # Q9UNA0
Ser262-Pro622
Accession # Q9UNA0
Specificity
Detects human ADAMTS5 in direct ELISAs and Western blots. In Western blots, less than 5% cross-reactivity with recombinant human (rh) ADAMTS1 and rhADAMTS-L1.2 is observed.
Clonality
Polyclonal
Host
Goat
Isotype
IgG
Applications for ADAMTS5 Antibody [Allophycocyanin]
Application
Recommended Usage
Immunoprecipitation
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Antigen Affinity-purified
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: ADAMTS5
Long Name
A Disintegrin-like and Metalloproteinase Domain with Thrombospondin Motifs 5
Alternate Names
ADAMTS11, ADMP-2, Aggrecanase 2
Gene Symbol
ADAMTS5
Additional ADAMTS5 Products
Product Documents for ADAMTS5 Antibody [Allophycocyanin]
Product Specific Notices for ADAMTS5 Antibody [Allophycocyanin]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...